Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$42.5B |
| 2 |
NVIDIA
NVDA
|
+$2.39B |
| 3 |
Walmart Inc
WMT
|
+$1.17B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.08B |
| 5 |
JPMorgan Chase
JPM
|
+$808M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.26B |
| 2 |
Amazon
AMZN
|
+$843M |
| 3 |
Xcel Energy
XEL
|
+$674M |
| 4 |
Global Payments
GPN
|
+$623M |
| 5 |
Palantir
PLTR
|
+$577M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 46.22% |
| 2 | Technology | 18.11% |
| 3 | Financials | 7.1% |
| 4 | Communication Services | 5.53% |
| 5 | Consumer Discretionary | 5.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2326
MarineMax
HZO
$1.16B
| $2.05M | ﹤0.01% |
75,795
-25,256
| -25% | -$701K |
2013 Q2
51 quarters
|
|
|
CBC
2327
Central Bancompany Inc
CBC
$7.63B
| $2.05M | ﹤0.01% |
+85,612
| New | +$2.07M |
2026 Q1
0 quarters
|
|
2328
REX American Resources
REX
$1.45B
| $2.05M | ﹤0.01% |
44,895
-38,703
| -46% | -$1.4M |
2013 Q2
51 quarters
|
|
2329
Americold
COLD
$4B
| $2.05M | ﹤0.01% |
178,507
-388,245
| -69% | -$4.86M |
2018 Q1
32 quarters
|
|
2330
Genco Shipping & Trading
GNK
$1.2B
| $2.04M | ﹤0.01% |
90,628
+40,226
| +80% | +$861K |
2017 Q2
35 quarters
|
|
2331
Northwest Bancshares
NWBI
$2.21B
| $2.03M | ﹤0.01% |
160,254
-127,197
| -44% | -$1.6M |
2016 Q1
40 quarters
|
|
2332
RH
RH
$2.3B
| $2.03M | ﹤0.01% |
14,517
-22,960
| -61% | -$4.18M |
2013 Q2
51 quarters
|
|
2333
Independent Bank Corp
IBCP
$801M
| $2.03M | ﹤0.01% |
60,891
-22,068
| -27% | -$759K |
2017 Q1
36 quarters
|
|
2334
Ryman Hospitality Properties
RHP
$8.42B
| $2.02M | ﹤0.01% |
21,943
-78,866
| -78% | -$7.57M |
2013 Q2
51 quarters
|
|
2335
Brinker International
EAT
$8.39B
| $2.02M | ﹤0.01% |
14,181
-89,831
| -86% | -$13.7M |
2013 Q2
51 quarters
|
|
2336
Box
BOX
$4.73B
| $2.02M | ﹤0.01% |
85,632
-200,185
| -70% | -$5.04M |
2015 Q1
44 quarters
|
|
2337
Independent Bank
INDB
$3.77B
| $2.01M | ﹤0.01% |
26,690
-66,814
| -71% | -$5.24M |
2016 Q1
40 quarters
|
|
2338
Independence Realty Trust
IRT
$3.42B
| $1.99M | ﹤0.01% |
133,929
-390,946
| -74% | -$6.42M |
2015 Q2
43 quarters
|
|
2339
Cullinan Oncology
CGEM
$948M
| $1.99M | ﹤0.01% |
140,295
-129,360
| -48% | -$1.66M |
2022 Q1
16 quarters
|
|
|
HTB
2340
HomeTrust Bancshares
HTB
$764M
| $1.99M | ﹤0.01% |
46,631
-17,799
| -28% | -$767K |
2013 Q2
51 quarters
|
|
2341
FB Financial Corp
FBK
$2.65B
| $1.99M | ﹤0.01% |
38,286
-55,969
| -59% | -$3.15M |
2017 Q1
36 quarters
|
|
2342
Celanese
CE
$4.92B
| $1.99M | ﹤0.01% |
30,195
+18,879
| +167% | +$986K |
2013 Q2
51 quarters
|
|
2343
Amalgamated Financial
AMAL
$1.44B
| $1.98M | ﹤0.01% |
50,956
-35,360
| -41% | -$1.34M |
2022 Q1
16 quarters
|
|
2344
PUT
AstraZeneca
AZN
$243B
| $1.97M | ﹤0.01% |
10,000
| – | – |
2024 Q3
6 quarters
|
|
2345
Viridian Therapeutics
VRDN
$2.2B
| $1.97M | ﹤0.01% |
100,598
-143,675
| -59% | -$4.27M |
2022 Q1
16 quarters
|
|
2346
1st Source
SRCE
$2.08B
| $1.97M | ﹤0.01% |
28,429
-22,069
| -44% | -$1.49M |
2016 Q1
40 quarters
|
|
2347
Nice
NICE
$6.66B
| $1.97M | ﹤0.01% |
17,823
-595
| -3% | -$67.9K |
2016 Q1
40 quarters
|
|
2348
Tarsus Pharmaceuticals
TARS
$3.44B
| $1.96M | ﹤0.01% |
28,004
-52,780
| -65% | -$3.69M |
2022 Q1
16 quarters
|
|
2349
Butterfly Network
BFLY
$2.36B
| $1.96M | ﹤0.01% |
486,103
+145,278
| +43% | +$561K |
2022 Q1
16 quarters
|
|
2350
StoneCo
STNE
$2.16B
| $1.96M | ﹤0.01% |
138,959
-303,673
| -69% | -$4.67M |
2018 Q4
29 quarters
|
|
Similar funds
Barclays's Q1 2026 Portfolio in Review
As of Q1 2026, Barclays held 5,572 positions worth $416B, down 0.11% from $417B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Barclays deployed $42.4B of net new capital in Q1 2026, opening 397 new positions and adding to 1,219 existing holdings. Its largest new stake was Sunbelt Rentals Holdings: 1,528,635 shares worth $99.5M.
By sector, the portfolio is most concentrated in Miscellaneous at 46% of assets, up from 44% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Tesla, an estimated $1.26B trimmed.
- Barclays's largest Q1 2026 buy was Sunbelt Rentals Holdings: 1,528,635 shares worth $99.5M.
- Barclays added most to iShares MSCI Emerging Markets ETF in Q1 2026, an estimated $42.5B increase.
- Barclays's biggest Q1 2026 reduction was Tesla, cutting an estimated $1.26B.
- Barclays fully exited CyberArk in Q1 2026, selling an estimated $232M.
- Barclays's ten largest holdings make up 37% of its $416B portfolio in Q1 2026.
- Barclays opened 397 new positions and closed 563 in Q1 2026.
- Barclays's portfolio value fell 0.11% quarter-over-quarter to $416B.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.